Kyle M. Devins

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Hyoung Kim, Haineng Xu, Erin George et al. · Nature Communications · 2020 · 369 citations · Full text

Medicine, Oncology, Pharmacology +17

CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models

Haineng Xu, Erin George, Yasuto Kinose et al. · Cell Reports Medicine · 2021 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +17

HYPERsol: High-Quality Data from Archival FFPE Tissue for Clinical Proteomics

Dylan M. Marchione, Ilyana Ilieva, Kyle M. Devins et al. · Journal of Proteome Research · 2020 · 60 citations · Full text

Life Sciences, Biomedical Sciences, Pathology +17

Embryonal Rhabdomyosarcoma of the Uterine Cervix

Kyle M. Devins, Robert H. Young, Mariachristina Ghioni et al. · The American Journal of Surgical Pathology · 2022 · 36 citations

Veterinary Medicine, Oncology, Pathology +14

Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young

Kyle M. Devins, Robert H. Young, Jaclyn C. Watkins · Histopathology · 2021 · 28 citations

Medicine, Oncology, Pathology +16